Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00185094 · ClinicalTrials.gov registry record · Phase 4

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

A Phase 4 study of Hypertension and Insulin Resistance, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target
10
Study locations

NCT00185094 is a Phase 4 study of Hypertension and Insulin Resistance that has completed, run by Daiichi Sankyo. The registered enrollment target is 60 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00185094, a Phase 4 study of Hypertension and Insulin Resistance, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target
10
Study locations

Study Summary

To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.

Conditions Studied

Hypertension Insulin Resistance Metabolic Syndrome

Interventions

  • DRUG Atenolol
  • DRUG Olmesartan medoxomil
  • DRUG Losartan potassium

Study Locations (10)

Texas

  • - Dallas
  • - San Antonio

Alabama

  • - Birmingham

California

  • - San Diego

Florida

  • - Miami

Indiana

  • - Indianapolis

Maryland

  • - Baltimore

Massachusetts

  • - Boston

Minnesota

  • - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2004-02
Est. Completion 2005-07
Phase Phase 4

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00185094

The ClinicalTrials.gov registry entry for NCT00185094 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Atenolol is the first listed.

NCT00185094 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Texas, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT00185094 about?

NCT00185094 is a clinical study titled "A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin". To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.

What is the current status of trial NCT00185094?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2004-02. Estimated completion is 2005-07.

What conditions does trial NCT00185094 study?

This clinical trial studies the following conditions: Hypertension, Insulin Resistance, Metabolic Syndrome.

What interventions are being tested in trial NCT00185094?

The interventions under investigation include: Atenolol (DRUG), Olmesartan medoxomil (DRUG), Losartan potassium (DRUG).

Who is sponsoring clinical trial NCT00185094?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00185094 being conducted?

This trial has 10 study locations across Alabama, California, Florida, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Insulin Resistance

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.